Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03521180 · ClinicalTrials.gov registry record
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
A clinical trial, sponsored by Celgene.
- Completed
- Registry status
- 5
- Enrollment target
NCT03521180 is a clinical trial that has completed, run by Celgene. The registered enrollment target is 5 participants.
The verdict
NCT03521180 has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This is a model development, open label, no therapeutic treatment, three sequential group, short term-gluten challenge study in subjects with celiac disease. Immune responses are evaluated following gluten challenge. Approximately fifteen subjects with celiac disease will be enrolled in up to three sequential groups (5 subjects per group).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2019-07-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03521180
The ClinicalTrials.gov registry entry for NCT03521180 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03521180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03521180 about?
NCT03521180 is a clinical study titled "A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease". This is a model development, open label, no therapeutic treatment, three sequential group, short term-gluten challenge study in subjects with celiac disease. Immune responses are evaluated following gluten challenge. Approximately fifteen subjects with celiac disease will be enrolled in up to three...
What is the current status of trial NCT03521180?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2018-05-11. Estimated completion is 2019-07-18.
Who is sponsoring clinical trial NCT03521180?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.